Mr Fogelman has more than 30 years of financial and accounting experience and has previously worked with International Aluminum Corporation.
CytRx president and CEO Steven Kriegsman said: “Mitch is a highly accomplished senior financial executive with proven leadership and managerial skills in a public company environment. He brings a full breadth of financial operations expertise, as well as proven capabilities in developing and implementing strategic plans. His energetic, team-oriented, hands-on approach makes him an ideal fit with our corporate culture and I am delighted to welcome him to CytRx.”
Mr Fogelman said: “I am excited to join the highly dedicated team as preparations are underway to move forward with the clinical development of important new treatments for patients afflicted with devastating medical conditions.”